Dr. Peter McCullough has an impressive list of credentials1 — he’s an internist, cardiologist, epidemiologist and a full professor of medicine at Texas A&M College of Medicine in Dallas and is the editor of two medical journals and published hundreds of studies in the literature. He’s also among those brave and courageous persons speaking out about the dangers of COVID-19 jabs, and putting his medical license and future livelihood at risk by so doing.
“There’s a hunting that’s going on here that’s very disturbing,” McCullough said in an episode of Perspectives on the Pandemic.2 He was referring to state medical boards hunting down doctors and their and threatening revocation of their licenses based on the spreading of unidentified “misinformation.”
“This is absolutely astonishing that this is happening over a fair exchange of ideas,” he said. What is Dr. McCullough sharing that the powers that be don’t want you to hear? It’s about COVID-19 injections and, to sum it up in a sentence, “It’s not working and it’s causing tremendous damage.”
COVID Jab Efficacy and Safety Overstated From the Start
In the U.S., Operation Warp Speed is the federal effort that fast-tracked COVID-19 jab candidates to market. Gene transfer technology platforms emerged as the frontrunners, including adenoviral DNA platforms or messenger RNA (mRNA) platforms designed to deliver genetic material to the human body.
Once the mRNA is injected, the body then takes up the genetic material and changes in some way. These technologies have been under study for years, in most cases being designed to replace a defective gene, which could potentially be used for cancer treatment, for example. Except historically, “all failed,” McCullough said.
In November 2020, however, Pfizer, in a joint venture with Germany-based BioNTech, announced that their mRNA-based injection was “more than 90% effective” in a Phase 3 trial.3 This does not mean that 90% of people who get injected will be protected from COVID-19, though, as it’s based on relative risk reduction (RRR).
The absolute risk reduction (ARR) for the jab is less than 1%. “Although the RRR considers only participants who could benefit from the jab, the absolute risk reduction (ARR), which is the difference between attack rates with and without a jab, considers the whole population. ARRs tend to be ignored because they give a much less impressive effect size than RRRs,” researchers wrote in The Lancet Microbe in April 2021.4
Nonetheless, the jabs received emergency use authorization. By giving the emergency authorization, not approval, the jab administration constituted a research trial, with the sponsors being the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration. According to McCullough:5
“We’ve never had two government bodies together be a sponsor of a major research program. Shockingly, they did not have, and to this day they’ve never put together, an external critical event committee, an external data safety monitoring board or a human ethics committee. They had these committees in the registrational trials … and these are standard.